PALISADE BIO, INC.·4

Nov 22, 4:00 PM ET

Williams Donald Allen 4

4 · PALISADE BIO, INC. · Filed Nov 22, 2024

Insider Transaction Report

Form 4
Period: 2024-11-21
Transactions
  • Exercise/Conversion

    Comon Stock, par value $0.01

    2024-11-21+388728 total
Holdings
  • Comon Stock, par value $0.01

    (indirect: By Reporting Person's Defined Benefit Plan)
    3,000
Footnotes (1)
  • [F1]Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary